Ampyrone Identified as Potential Treatment for Hypopigmentation Disorders
A preclinical study has identified ampyrone, a compound related to nonsteroidal anti-inflammatory drugs (NSAIDs), as a promising agent for boosting melanin production in human skin. According to researchers at Weill Cornell Medicine and the National Eye Institute, this discovery could serve as the foundation for developing new therapies for hypopigmentation disorders. Understanding Hypopigmentation and the … Read more